Susquehanna International Group, LLP Evolus, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	$9.99 - $14.91 $4.87 Million - $7.27 Million	487,300 Added 1613.58%	517,500 $7.25 Million
Q4 2023 Feb 14, 2024	BUY	$7.6 - $10.53 $118,560 - $164,268	15,600 Added 106.85%	30,200 $318,000
Q3 2023 Nov 14, 2023	SELL	$7.15 - $10.2 $192,335 - $274,380	-26,900 Reduced 64.82%	14,600 $133,000
Q2 2023 Aug 11, 2023	BUY	$7.23 - $10.52 $219,069 - $318,756	30,300 Added 270.54%	41,500 $301,000
Q1 2023 May 16, 2023	SELL	$7.81 - $11.05 $110,902 - $156,910	-14,200 Reduced 55.91%	11,200 $94,000
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.95 $441,404 - $605,915	-67,700 Reduced 72.72%	25,400 $190,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $509,056 - $900,032	65,600 Added 238.55%	93,100 $749,000

169

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $679M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.